Skip to main content

Arbutus Biopharma Corp

ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001447028

No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Arbutus Biopharma Corp as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
+15 vs. Q2 2022
Shares held
46.6M
+2.29M (+5.2%) vs. Q2 2022
Total value
$89.1M
−$30.9M (−25.8%) vs. Q2 2022
New holders
20
44 more added
Sold out
5
33 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ABUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 127 institutions
Q1 2021: 94 institutionsQ2 2021: 91 institutionsQ3 2021: 100 institutionsQ4 2021: 123 institutionsQ1 2022: 119 institutionsQ2 2022: 113 institutionsQ3 2022: 127 institutionsQ4 2022: 114 institutionsQ1 2023: 122 institutionsQ2 2023: 111 institutionsQ3 2023: 99 institutionsQ4 2023: 112 institutionsQ1 2024: 119 institutionsQ2 2024: 131 institutionsQ3 2024: 144 institutionsQ4 2024: 154 institutionsQ1 2025: 168 institutionsQ2 2025: 163 institutionsQ3 2025: 166 institutionsQ4 2025: 172 institutionsQ1 2026: 167 institutionsQ2 2026: 176 institutions
Value heldQ3 2022: $89.1M
Q1 2021: $86.5MQ2 2021: $87.6MQ3 2021: $149.8MQ4 2021: $154.4MQ1 2022: $130.6MQ2 2022: $120.0MQ3 2022: $89.1MQ4 2022: $126.3MQ1 2023: $189.3MQ2 2023: $152.4MQ3 2023: $143.8MQ4 2023: $197.4MQ1 2024: $215.2MQ2 2024: $298.4MQ3 2024: $389.2MQ4 2024: $340.3MQ1 2025: $390.1MQ2 2025: $365.0MQ3 2025: $536.4MQ4 2025: $586.9MQ1 2026: $625.4MQ2 2026: $674.9M
Institutions holding ABUS and their total value by quarter
QuarterHoldersValue
Q2 2026176$674.9M
Q1 2026167$625.4M
Q4 2025172$586.9M
Q3 2025166$536.4M
Q2 2025163$365.0M
Q1 2025168$390.1M
Q4 2024154$340.3M
Q3 2024144$389.2M
Q2 2024131$298.4M
Q1 2024119$215.2M
Q4 2023112$197.4M
Q3 202399$143.8M
Q2 2023111$152.4M
Q1 2023122$189.3M
Q4 2022114$126.3M
Q3 2022127$89.1M
Q2 2022113$120.0M
Q1 2022119$130.6M
Q4 2021123$154.4M
Q3 2021100$149.8M
Q2 202191$87.6M
Q1 202194$86.5M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Arbutus Biopharma Corp; share changes are against Q2 2022.

Institutions holding ABUS in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Kepos Capital LP200,000$382.0K0.05%00.0%Unchanged
Parallax Volatility Advisers, L.P.200,528$383.0K0.01%+176+0.1%Added
Morgan Stanley212,006$405.0K0.00%−6,948−3.2%Reduced
Jacob Asset Management of New York LLC220,000$420.0K0.46%00.0%Unchanged
DekaBank Deutsche Girozentrale250,000$485.0K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc287,419$549.0K0.00%−535−0.2%Reduced
Susquehanna International Group, LLP289,562$553.0K0.00%+4,137+1.4%Added
Nuveen Asset Management, LLC326,140$623.0K0.00%−1,185−0.4%Reduced
Bank of Montreal320,003$707.0K0.00%−8,459−2.6%Reduced
Bank of New York Mellon Corp385,461$736.0K0.00%+30,612+8.6%Added
Marshall Wace, LLP392,932$751.0K0.00%+392,932New
Primecap Management Co423,300$809.0K0.00%00.0%Unchanged
Wellington Management Group LLP433,564$828.0K0.00%−71,700−14.2%Reduced
Goldman Sachs Group Inc651,036$1.24M0.00%−80,129−11.0%Reduced
Boothbay Fund Management, LLC767,400$1.47M0.05%+215,132+39.0%Added
Northern Trust Corp900,547$1.72M0.00%+3,575+0.4%Added
Oasis Management Co Ltd.1,026,672$1.96M0.34%+1,026,672New
Advisor Group Holdings, Inc.1,364,523$2.61M0.01%00.0%Unchanged
Assenagon Asset Management S.A.1,895,161$3.62M0.02%−226,245−10.7%Reduced
FourWorld Capital Management LLC2,000,090$3.82M7.44%+199,090+11.1%Added
Geode Capital Management, LLC2,009,840$3.84M0.00%+224,798+12.6%Added
State Street Corp2,011,376$3.84M0.00%+52,456+2.7%Added
Millennium Management LLC3,510,188$6.70M0.01%−648,876−15.6%Reduced
Hudson Bay Capital Management LP4,961,895$9.48M0.10%+293,668+6.3%Added
Vanguard Group Inc5,265,884$10.1M0.00%+64,485+1.2%Added
Two Seas Capital LP5,653,917$10.8M12.39%+2,152,041+61.5%Added
BlackRock Inc.7,467,818$14.3M0.00%−72,564−1.0%Reduced
Brookfield Asset Management Inc.0$00.00%−1,915,000−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−64,400−100.0%Sold out
Virtu Financial LLC0$00.00%−52,722−100.0%Sold out
Sigma Planning Corp0$00.00%−11,000−100.0%Sold out
Sterling Investment Advisors, Ltd.0$00.00%−4,000−100.0%Sold out
Lake Point Wealth Management––––Not filed